PuSH - Publication Server of Helmholtz Zentrum München

Shortening the paths to type 1 diabetes mellitus prevention.

Nat. Rev. Endocrinol. 17, 73–74 (2021)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
The development and application of effective immunotherapies for type 1 diabetes mellitus has lagged behind our ability to identify and stage individuals in pre-clinical stages of disease. This Year in Review addresses advances in immunotherapy aimed towards prevention and our readiness to roll out screening in the broader population.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Editorial
Corresponding Author
ISSN (print) / ISBN 1759-5029
e-ISSN 1759-5037
Quellenangaben Volume: 17, Issue: , Pages: 73–74 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place New York, NY
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute for Pancreatic Beta Cell Research (IPI)
Institute of Diabetes and Obesity (IDO)
Institute of Diabetes Research Type 1 (IDF)